Sema4, a patient-centered healthcare data analytics company, announced the completion of its business combination with CM Life Sciences, a special purpose acquisition company (SPAC) sponsored

Sema4, a patient-centered healthcare data analytics company, announced the completion of its business combination with CM Life Sciences, a special purpose acquisition company (SPAC) sponsored
The year 2020 is on course to become the year of the special purpose acquisition companies (SPACs) also known as blank check companies, in the
Sema4, a patient-centered healthcare data analytics company, and CM Life Sciences, a special purpose acquisition company (SPAC), sponsored by affiliates of Casdin Capital and Corvex
Biofourmis, developer of Biovitals, a personalized AI-powered health analytics platform, raised $100 million in a Series C financing. The round was led by SoftBank Vision
Sema4, a patient-centered healthcare data analytics platform, announced that funds managed by BlackRock led its Series C financing round of $121 million at a post-money